Michael B. Lilly
Affiliations: | Loma Linda University, Loma Linda, United States |
Area:
Molecular Biology, Microbiology BiologyGoogle:
"Michael Lilly"Children
Sign in to add trainee| Sheldon L. Holder | grad student | 2005 | Loma Linda University |
| Eva Sahakian | grad student | 2010 | Loma Linda University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dincman TA, Karam JAQ, Giordano A, et al. (2024) Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer. Frontiers in Oncology. 13: 1202277 |
| Babatunde OA, Pearce JL, Jefferson MS, et al. (2022) Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors. Diseases (Basel, Switzerland). 10 |
| Swami U, Zimmerman RM, Nussenzveig RH, et al. (2022) Genomic landscape of advanced prostate cancer patients with versus mutations as detected by comprehensive genomic profiling of cell-free DNA. Frontiers in Oncology. 12: 966534 |
| Bray AW, Duan R, Malalur P, et al. (2022) Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer. The Prostate |
| Wang X, Zhou Z, Turner D, et al. (2022) Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals. Journal of Immunology Research. 2022: 2574964 |
| Krisanits BA, Woods P, Nogueira LM, et al. (2022) Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts. Translational Oncology. 17: 101350 |
| Halbert CH, Jefferson M, Allen CG, et al. (2021) Racial Differences in Patient Portal Activation and Research Enrollment Among Patients With Prostate Cancer. Jco Clinical Cancer Informatics. 5: 768-774 |
| Moses M, Niu A, Lilly MB, et al. (2020) Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer. Cancer Treatment and Research Communications. 24: 100193 |
| Halbert CH, Jefferson MS, Drake R, et al. (2020) Social and clinical determinants of physical activity in prostate cancer survivors. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer |
| Ledet EM, Lilly MB, Sonpavde G, et al. (2020) Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer. The Oncologist. 25: 327-333 |